Condition
Degenerative Joint Disease of Hip
Total Trials
4
Recruiting
1
Active
2
Completed
1
Success Rate
50.0%-37% vs avg
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 75/100
Termination Rate
25.0%
1 terminated out of 4 trials
Success Rate
50.0%
-36.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
100%
1 of 1 completed with results
Key Signals
1 with results50% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Active Not Recruiting1
Completed1
Recruiting1
Terminated1
Trial Success Rate
50.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT06792539Not ApplicableActive Not Recruiting
Evaluate the Safety and Effectiveness of the Polymotion Hip Resurfacing (PHR) System Compared to Total Hip Arthroplasty
NCT04754087Not ApplicableRecruiting
G7 Acetabular System With Vivacit-E or Longevity Liner PMCF Study
NCT03566082CompletedPrimary
Post-Approval Study of the R3 Biolox Delta Ceramic Acetabular System - Europe
NCT04348968TerminatedPrimary
Maxera Large Cups - Canada
Showing all 4 trials